TB-500 is a synthetic analogue of thymosin beta-4 studied in cytoskeletal and cell-migration research models. Experimental literature evaluates its interaction with actin dynamics and downstream processes associated with extracellular matrix remodeling and angiogenic signaling. Laboratory investigations characterize pathway-level effects in controlled cell-based and animal systems without implying human outcomes.
Products will arrive in a lyophilized (powder) form to maximize stability and shelf life.
$69